Brainomix 360 e-ASPECTS

Brainomix Limited · K221564 · 2023-02-23

Brainomix 360 e-ASPECTS is an AI-enabled medical device from Brainomix Limited, listed by FDA (510(k), K221564) with a decision date of 2023-02-23. Review panel: Radiology.

FDA submission numberK221564
Pathway510(k)
CompanyBrainomix Limited
Review panel (specialty)Radiology
FDA decision date2023-02-23
DecisionSubstantially Equivalent
Product codePOK
ClassificationComputer-Assisted Diagnostic Software For Lesions Suspicious For Cancer
Device class2
Regulation number892.2060
Review time (calendar days)268
Applicant countryGB

Official FDA database record · FDA AI-enabled device list

More devices from Brainomix Limited · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.